NPI Portal NPI Lookup & Verification

Synapse Therapeutics Inc

Synapse Therapeutics Inc is a healthcare organization registered as Community/Retail Pharmacy in Glendale, CA, holding Type 2 (organization) NPI 1225026594 since 2005. The authorized official on file is Arthur Avetisyan, Ceo/Sec/Cfo/Dir/President.

✓ Active NPI ✓ Valid NPI checksum

NPI 1225026594
Entity type Organization (Type 2)
Legal business name Synapse Therapeutics Inc
Other name <Unavail>
Practice address 501 WESTERN AVE, Glendale, CA, 91201
Phone 8182425887
Fax 8185076324
Enumeration date 2005-10-11
Last updated in NPPES 2023-10-10

Authorized official

Name Arthur Avetisyan
Title Ceo/Sec/Cfo/Dir/President
Phone 8182425887

Taxonomy & classification

Taxonomy code Specialty Primary License State
3336C0003X Community/Retail Pharmacy Primary
Copy-ready billing details
Provider: Synapse Therapeutics Inc
NPI: 1225026594
Taxonomy: 3336C0003X (Community/Retail Pharmacy)
Address: 501 WESTERN AVE, Glendale, CA, 91201

Providers at this address

NPI Name Type Specialty Location
1093447419 Jacqueline Valdez-Bedikian Individual Pharmacist Glendale, CA
1154027357 Arthur Avetisyan Individual Pharmacist Glendale, CA
1235908765 Synapse Therapeutics Inc Organization Long Term Care Pharmacy Glendale, CA
1518800564 Gohar Narinyan Individual Pharmacist Glendale, CA

Verify this record

Cross-check NPI 1225026594 against the authoritative CMS record: view Synapse Therapeutics Inc on the official NPPES registry .

What is an NPI number?

A National Provider Identifier (NPI) is a unique 10-digit number that CMS assigns to every U.S. healthcare provider and organization under HIPAA. Type 1 NPIs identify individual providers; Type 2 NPIs identify organizations. The NPI appears on insurance claims, prescriptions, and credentialing paperwork, and never changes — even if the provider moves or changes specialty. Read the full guide or validate an NPI number.

Frequently asked questions

What is the NPI number for Synapse Therapeutics Inc?
The NPI for Synapse Therapeutics Inc is 1225026594, a Type 2 (organization) record in the CMS NPPES registry.
Who is the authorized official for Synapse Therapeutics Inc?
NPPES lists Arthur Avetisyan (Ceo/Sec/Cfo/Dir/President) as the authorized official for this organization.

Source: CMS NPPES (public data). Snapshot 2026-07-11. Provider record last updated 2023-10-10.